2023
Impact of COVID-19 on the gastrointestinal surgical oncology patient population
Bakkila B, Marks V, Kerekes D, Kunstman J, Salem R, Billingsley K, Ahuja N, Laurans M, Olino K, Khan S. Impact of COVID-19 on the gastrointestinal surgical oncology patient population. Heliyon 2023, 9: e18459. PMID: 37534012, PMCID: PMC10391949, DOI: 10.1016/j.heliyon.2023.e18459.Peer-Reviewed Original ResearchGI cancer surgeryPreoperative chemotherapyCancer surgerySurgical careCOVID-19 pandemicCOVID-19Tertiary referral centerOncology patient populationFirst COVID-19 waveGI cancer casesCOVID-19 burdenHigh COVID-19 burdenEmergency surgeryReferral centerCOVID-19 waveOncology visitsGastrointestinal cancerGI cancersPatient populationStudy criteriaCancer careTreatment characteristicsCancer casesCase volumePatients
2020
Perioperative complication rates following neoadjuvant therapy in pancreatic adenocarcinoma.
Deig C, Beneville B, Liu A, Kanwar A, Grossblatt-Wait A, Sheppard B, Gilbert E, Lopez C, Billingsley K, Nabavizadeh N, Thomas C, Grossberg A. Perioperative complication rates following neoadjuvant therapy in pancreatic adenocarcinoma. Journal Of Clinical Oncology 2020, 38: 688-688. DOI: 10.1200/jco.2020.38.4_suppl.688.Peer-Reviewed Original ResearchPerioperative complication rateNeoadjuvant therapyComplication ratePancreatic adenocarcinomaNeo-CRTUpfront resectionUpfront surgeryHospital lengthExact testComparable perioperative complication ratesSignificant differencesAcademic tertiary referral centerInstitutional cancer registryMedian hospital lengthNeoadjuvant radiation therapyPatients Undergoing ResectionTotal neoadjuvant therapyPost-operative mortalityTertiary referral centerResectable pancreatic adenocarcinomaAdditional surgical riskFisher's exact testT-testStudent's t-testUndergoing resection